Table 2.
Recent studies reporting long term (>2 years) outcomes of tubes in adult uveitic glaucoma.
| Procedure | Patients/ Eyes |
Diagnosis (%) | F/U (Months) |
Success Rate * (%) |
Complications (%) |
Secondary Procedures (%) | |
|---|---|---|---|---|---|---|---|
| Kubaisi (2017) [118] | AGV + FAI | 9/10 | Panuveitis 44.4 | RD 10 | |||
| Bao (2018) [102] | AGV | 57/66 | Unknown 35.8 Ankylosing spondylitis 31.3 |
53.3 ± 8.5 | 61.2 | Tube erosion 7.6% RD 3% |
40 |
| Voykov (2018) [119] | AGV | 17 | Fuchs | 36 | 38.4 | Tube erosion 23.5 Tube obstruction 23.5 Diplopia 4 |
35 |
| Yakin (2017) [120] | AGV | 35/47 | ABD | 57.7 ± 26.1 | 35.9 | Tube erosion 3.2 Early wound dehiscence 2.1 |
6.4 |
| Sungur (2017) [101] | AGV | 39/46 | Idiopathic anterior uveitis 17.3 Ankylosing spondilitis 17.3 Fuchs 17.3 |
51.9 ± 23 | 63 | Tube exposure 2.2 | |
| Tan (2018) [109] | BGI | 47/47 | Unknown 30 Fuchs 17 Sarcoidosis 13 |
63.6 ± 43.1 | 75 | Cornea decompensation 9 Hypotony maculopathy 11 |
17 |
| Chambra (2019) [110] | BGI | 42/34 | Sarcoidosis 31 Idiopathic 21 Tuberculosis 14 |
58.5. ± 20.8 | 76 | CME 5 Hypotony maculopathy 2 |
31 |
| Sisha (2020) [114] | AGV | 67 | Anterior uveitis 86 Panuveitis 7 Posterior 6 |
30 ± 4 | 63 | Tube exposure 12 | 45 |
| Sisha (2020) [114] | BGI | 70 | 33 ± 4 | 70 | Corneal edema 6 Tube exposure 4 Endophthalmitis 1 |
59 |
(*): according to the definition by the author; AGV: Ahmed Glaucoma Valve; FAI: fluocinolone implant; BGI: Baerveldt glaucoma implant; ABD: Adamantiades–Behcet’s disease; RD: retinal detachment.